Viewing nowAesmonte 4 mg Oral Disintegrating Tablet (Montelukast Sodium)
Montelukast Sodium 4.16mg
Orally disintegrating Tablet · Prescription medication
Kolon Pharmaceuticals Co., Ltd.

MFDS item code 201205414 · Approved 2012.06.05 · Insurance code 670303490
Prevention and long-term treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms
This medication helps prevent and continuously treat asthma. It is also used to relieve symptoms of seasonal and perennial allergic rhinitis. It is recommended to take this medication consistently as it plays an important role in maintaining respiratory health.
Take this medicine once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the dosing time should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet once daily in the evening.
Asthma or allergic rhinitis 4 mg oral disintegrating tablet Children 2~5 years of age: Take 4 mg of montelukast once daily by placing it on the tongue and swallowing without water once it has disintegrated. Administer this medicine 1 hour before or 2 hours after a meal.
This medication should not be administered to patients with phenylketonuria, a genetic disorder. This is because the artificial sweetener aspartame included in this product is broken down into phenylalanine in the body. The amount of aspartame in this medication should be minimized to below the recommended levels set by WHO, and the maximum daily dosage for adults is established. Patients who have had allergic reactions to this medication or any of its components should not take it. Additionally, this medication contains lactose, so patients with genetic issues such as lactose intolerance, lactase deficiency, or glucose-galactose malabsorption should also avoid taking it. This medication is not for use during acute asthma attacks; in case of acute symptoms, other emergency medications should be used. Even when using this medication for asthma treatment, it is advised to always carry a short-acting inhaled bronchodilator for emergency situations. When reducing the dose of inhaled corticosteroids, it should be done gradually under medical supervision, as sudden changes can be dangerous. During the use of this medication, side effects such as drowsiness, headache, abdominal pain, rash, and respiratory infections may occur; if symptoms are severe, a consultation with a physician is recommended. Notably, in rare cases among patients taking this medication, serious side effects such as vasculitis or eosinophilia may occur, so if there are skin rashes, worsening lung symptoms, heart problems, etc., immediate notification to medical personnel is required. Patients with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should avoid taking these drugs while on this medication. Pregnant women should only take this medication after consulting with a doctor if necessary, and caution is required during breastfeeding. In children, especially infants under 6 months, safety and efficacy have not been established, so use should be avoided. This medication is sensitive to light, so it is important to open it just before taking and to take it immediately after opening. No significant drug interactions have been reported when this medication is taken with others, but caution is necessary when used with drugs that induce certain liver metabolic enzymes. In case of overdose, there is no specific antidote, so general treatment should be followed according to symptoms and instructions from a physician. Finally, this medication should be taken continuously even when there are no symptoms of asthma or allergic rhinitis, and if symptoms worsen or any unusual symptoms appear, it is essential to consult a physician.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in an opaque container. Additionally, it is important to store it at room temperature between 1 degree and 30 degrees Celsius to maintain its effectiveness.
White or off-white circular oral disintegrating tablet
28 tablets (7 tablets/PTP X 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMontelukast Sodium 4.16mg
Orally disintegrating Tablet · Prescription medication
Kolon Pharmaceuticals Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.